EUVIMEDEUVIMED entdecken
Crossref

Antibiotic Susceptibility and Genetic Diversity of Helicobacter pylori from a Tertiary Care Hospital in North India

Biomedical and Biotechnology Research Journal · 2024

DOI: 10.4103/bbrj.bbrj_102_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical and Biotechnology Research Journal, 2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Safiya Arfi1, Prateek Sharma1, Mithun Kumar2, Shubham Mehra1, Kunal Das3, Ashwini Setya2, Rajashree Das1 1Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, 3Department of Gastroenterology, Yashoda Super Specialty Hospital, Ghaziabad, Uttar Pradesh, 2Department of Gastroenterology and Hepatology, Max Super Speciality Hospital, New Delhi, India Address for correspondence: Dr. Rajashree Das, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida - 201 301, Uttar Pradesh, India. E-mail: [email protected] ORCID: https://orcid.org/0000-0003-1202-4942 Background: This study aimed to assess the antibiotic susceptibility of drugs commonly used for Helicobacter pylori (H. pylori) eradication and understand the interplay between genetic diversity of H. pylori virulence genes and antibiotic resistance in North India. Materials and Methods: A total of 58 H. pylori strains isolated from patients with various gastrointestinal diseases were analyzed. The minimum inhibitory concentrations of antibiotics were determined using the agar dilution method. Statistical analysis was performed using the Chi-square test and Fisher’s exact test, with significance set at a P value of 0.05. Data visualization was conducted using RStudio 4.0.

Results

The prevalence of antibiotic resistance was observed as follows: metronidazole (MTZ) (39.6%), tetracycline (TET) (20.7%), clarithromycin (CLA) (17.2%), amoxicillin (AMX) (20.7%), furazolidone (FZD) (34.4%), levofloxacin (LVFX) (70.7%), and rifabutin (RIF) (17.2%). Resistance patterns included cases with no resistance (10.3%), single-drug resistance (24.1%), dual resistance (32.7%), triple resistance (12%), and multidrug resistance (MDR) (19%). The resistance rates in MTZ, CLA, and RIF were significantly higher in females compared to males (P = 0.005, P = 0.002, and P = 0.02, respectively). 48.27% of H. pylori strains were cagA positive, while 51.7% were cagA negative. The vacA s2m2 allele predominated in 50% of H. pylori-positive patients, followed by s1m1 (29.31%), s1m2 (17.2%), and s2m1 (3.4%). Although we did not find any significant difference in the prevalence of antibiotic resistance with H. pylori virulence genes.

Conclusion

TET, AMX, CLA, and RIF were effective against H. pylori infections, while further studies are needed on LVFX resistance. Gender differences showed females with higher antibiotic resistance than males. However, no clear association was found between antibiotic resistance and H. pylori virulence genes. Keywords: Antibiotic resistance, antibiotics, Helicobacter pylori, multidrug resistance, virulence genes

Zitieren

APA

(2024). Antibiotic Susceptibility and Genetic Diversity of Helicobacter pylori from a Tertiary Care Hospital in North India. Biomedical and Biotechnology Research Journal. https://doi.org/10.4103/bbrj.bbrj_102_24

Vancouver

Antibiotic Susceptibility and Genetic Diversity of Helicobacter pylori from a Tertiary Care Hospital in North India. Biomedical and Biotechnology Research Journal. 2024. doi:10.4103/bbrj.bbrj_102_24

BibTeX
@article{euvimed2024,
  title = {Antibiotic Susceptibility and Genetic Diversity of Helicobacter pylori from a Tertiary Care Hospital in North India},
  journal = {Biomedical and Biotechnology Research Journal},
  year = {2024},
  doi = {10.4103/bbrj.bbrj_102_24}
}
Kostenlos starten →